Features
After years of “sleep,” Bloomage faces biotech’s hard realities with a bet on science
Chair Zhao Yan is steering the company away from hype-driven marketing, investing in synthetic biology to rebuild growth and credibility.
Features
Chair Zhao Yan is steering the company away from hype-driven marketing, investing in synthetic biology to rebuild growth and credibility.